Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
China In-Vitro Diagnostics Research Report 202: A $28.13 Billion Market by 2030, Driven by High Burden of Chronic and Infectious Diseases | ||
By: PR Newswire Association LLC. - 16 Mar 2024 | Back to overview list |
|
DUBLIN , March 15, 2024 /PRNewswire/ -- The "China In-Vitro Diagnostics Market (By Segment, Company), Size, Share, Regulations, Reimbursement, Major Deals, Trends, Key Company Profiles, Sales Analysis, and Recent Developments - Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. China's in-vitro diagnostics market is predicted to reach US$ 28.13 Billion by 2030, from US$ 11.96 Billion in 2023 3. China is the largest in-vitro diagnostics market in the Asia-Pacific region, and only second to the United States in terms of value. In-vitro diagnostics refers to the diagnosis of disease or other conditions of the human body through the collection, preparation, and testing of human samples with reagents, instruments, and systems. China is facing the challenges of fighting infectious diseases including HBV, TB, HCV, and HIV, as well as various chronic diseases and cancer. In-vitro diagnostics play an important role in the detection of infectious and chronic diseases. Due to the upsurge in the geriatric population and the high burden of chronic and infectious diseases, like diabetes, cancer, and COVID-19, the China IVD market is slated to show significant growth, as these chronic disorders can be diagnosed and monitored using in-vitro diagnostics products. Moreover, the Chinese government is taking several initiatives to improve the healthcare sector in the country. For instance, The State Council issued a guideline to implement the country's Healthy China initiative to diminish the incidence of disability among elderly people aged between 65 and 74 years by offering medical and health services. Such initiatives by the government are expected to boost market growth over the forecast period. However, a lack of proper reimbursement and a stringent regulatory framework restricts the market's growth. China In-Vitro Diagnostics Market - Recent Developments
By Segment: China In-Vitro Diagnostics Market and Forecast - Key Takeaways
China In-Vitro Diagnostics Market - Company Analysis
China IVD Market - Key Company Profiles
Profiles of Private Clinical Labs and Diagnostic Services Companies in China
This 282 Page report with 43 Figures and 5 Tables has been analyzed from 12 View Points:
China IVD Market - By Application Segment
For more information about this report visit https://www.researchandmarkets.com/r/kz3uhv About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets For E.S.T Office Hours Call +1-917-300-0470 U.S. Fax: 646-607-1907 Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/china-in-vitro-diagnostics-research-report-202-a-28-13-billion-market-by-2030--driven-by-high-burden-of-chronic-and-infectious-diseases-302090347.html SOURCE Research and Markets |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |